Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 341

1.

Foreign-Body Granulomata Caused by Injected Permanent Filler Masquerading as Cutaneous Sarcoidosis.

Scofield-Kaplan SM, Patel SY, Mueller A, Ford WC, Evers BM, Hogan RN, Mancini R.

Ophthalmic Plast Reconstr Surg. 2019 Mar 26. doi: 10.1097/IOP.0000000000001385. [Epub ahead of print]

PMID:
30921058
2.

Kinase suppressor of Ras 1 and Exo70 promote fatty acid-stimulated neurotensin secretion through ERK1/2 signaling.

Rock S, Li X, Song J, Townsend CM Jr, Weiss HL, Rychahou P, Gao T, Li J, Evers BM.

PLoS One. 2019 Mar 27;14(3):e0211134. doi: 10.1371/journal.pone.0211134. eCollection 2019.

3.

S100A4 alters metabolism and promotes invasion of lung cancer cells by up-regulating mitochondrial complex I protein NDUFS2.

Liu L, Qi L, Knifley T, Piecoro DW, Rychahou P, Liu J, Mitov MI, Martin J, Wang C, Wu J, Weiss HL, Butterfield DA, Evers BM, O'Connor KL, Chen M.

J Biol Chem. 2019 May 3;294(18):7516-7527. doi: 10.1074/jbc.RA118.004365. Epub 2019 Mar 18.

PMID:
30885944
4.

Induction of AMPK activation by N,N'-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers.

Johnson J, Rychahou P, Sviripa VM, Weiss HL, Liu C, Watt DS, Evers BM.

PLoS One. 2019 Mar 15;14(3):e0209392. doi: 10.1371/journal.pone.0209392. eCollection 2019.

5.

Impact of the Affordable Care Act on Colorectal Cancer Screening, Incidence, and Survival in Kentucky.

Gan T, Sinner HF, Walling SC, Chen Q, Huang B, Tucker TC, Patel JA, Evers BM, Bhakta AS.

J Am Coll Surg. 2019 Apr;228(4):342-353.e1. doi: 10.1016/j.jamcollsurg.2018.12.035. Epub 2019 Feb 22.

PMID:
30802505
6.

Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD.

Pottier C, Ren Y, Perkerson RB 3rd, Baker M, Jenkins GD, van Blitterswijk M, DeJesus-Hernandez M, van Rooij JGJ, Murray ME, Christopher E, McDonnell SK, Fogarty Z, Batzler A, Tian S, Vicente CT, Matchett B, Karydas AM, Hsiung GR, Seelaar H, Mol MO, Finger EC, Graff C, Öijerstedt L, Neumann M, Heutink P, Synofzik M, Wilke C, Prudlo J, Rizzu P, Simon-Sanchez J, Edbauer D, Roeber S, Diehl-Schmid J, Evers BM, King A, Mesulam MM, Weintraub S, Geula C, Bieniek KF, Petrucelli L, Ahern GL, Reiman EM, Woodruff BK, Caselli RJ, Huey ED, Farlow MR, Grafman J, Mead S, Grinberg LT, Spina S, Grossman M, Irwin DJ, Lee EB, Suh E, Snowden J, Mann D, Ertekin-Taner N, Uitti RJ, Wszolek ZK, Josephs KA, Parisi JE, Knopman DS, Petersen RC, Hodges JR, Piguet O, Geier EG, Yokoyama JS, Rissman RA, Rogaeva E, Keith J, Zinman L, Tartaglia MC, Cairns NJ, Cruchaga C, Ghetti B, Kofler J, Lopez OL, Beach TG, Arzberger T, Herms J, Honig LS, Vonsattel JP, Halliday GM, Kwok JB, White CL 3rd, Gearing M, Glass J, Rollinson S, Pickering-Brown S, Rohrer JD, Trojanowski JQ, Van Deerlin V, Bigio EH, Troakes C, Al-Sarraj S, Asmann Y, Miller BL, Graff-Radford NR, Boeve BF, Seeley WW, Mackenzie IRA, van Swieten JC, Dickson DW, Biernacka JM, Rademakers R.

Acta Neuropathol. 2019 Jun;137(6):879-899. doi: 10.1007/s00401-019-01962-9. Epub 2019 Feb 9.

PMID:
30739198
7.

Integrating a 92-Gene Expression Analysis for the Management of Neuroendocrine Tumors of Unknown Primary

Chauhan A, Farooqui Z, Silva SR, Murray A, Hodges KB, Yu Q, Myint ZW, Raajesekar AK, Weiss H, Arnold S, Evers BM, Anthony L.

Asian Pac J Cancer Prev. 2019 Jan 25;20(1):113-116.

8.

Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer.

Liu J, Duan Z, Guo W, Zeng L, Wu Y, Chen Y, Tai F, Wang Y, Lin Y, Zhang Q, He Y, Deng J, Stewart RL, Wang C, Lin PC, Ghaffari S, Evers BM, Liu S, Zhou MM, Zhou BP, Shi J.

Nat Commun. 2018 Dec 5;9(1):5200. doi: 10.1038/s41467-018-07258-y.

9.

Unusual Location for a Periorbital Dermoid Cyst.

Scofield-Kaplan SM, Sobti D, Evers BM, Hogan RN, Mancini R.

Ophthalmic Plast Reconstr Surg. 2018 Nov/Dec;34(6):e208-e209. doi: 10.1097/IOP.0000000000001255.

PMID:
30418405
10.

Modulation of Mutant KrasG12D -Driven Lung Tumorigenesis In Vivo by Gain or Loss of PCDH7 Function.

Zhou X, Padanad MS, Evers BM, Smith B, Novaresi N, Suresh S, Richardson JA, Stein E, Zhu J, Hammer RE, O'Donnell KA.

Mol Cancer Res. 2019 Feb;17(2):594-603. doi: 10.1158/1541-7786.MCR-18-0739. Epub 2018 Nov 8.

PMID:
30409919
11.

De Novo Fatty Acid Synthesis-Driven Sphingolipid Metabolism Promotes Metastatic Potential of Colorectal Cancer.

Jafari N, Drury J, Morris AJ, Onono FO, Stevens PD, Gao T, Liu J, Wang C, Lee EY, Weiss HL, Evers BM, Zaytseva YY.

Mol Cancer Res. 2019 Jan;17(1):140-152. doi: 10.1158/1541-7786.MCR-18-0199. Epub 2018 Aug 28.

PMID:
30154249
12.

Development of murine bariatric surgery models: lessons learned.

Frohman HA, Rychahou PG, Li J, Gan T, Evers BM.

J Surg Res. 2018 Sep;229:302-310. doi: 10.1016/j.jss.2018.04.022. Epub 2018 May 10.

13.

Capecitabine and Temozolomide in Neuroendocrine Tumor of Unknown Primary.

Chauhan A, Farooqui Z, Murray LA, Weiss HL, War Myint Z, Raajasekar AKA, Evers BM, Arnold S, Anthony L.

J Oncol. 2018 May 7;2018:3519247. doi: 10.1155/2018/3519247. eCollection 2018.

14.

FFAR4 Is Involved in Regulation of Neurotensin Release From Neuroendocrine Cells and Male C57BL/6 Mice.

Li J, Song J, Li X, Rock SB, Sinner HF, Weiss HL, Weiss T, Townsend CM Jr, Gao T, Evers BM.

Endocrinology. 2018 Aug 1;159(8):2939-2952. doi: 10.1210/en.2018-00284.

15.

Remote acoustic sensing as a safety mechanism during exposure of metal implants to alternating magnetic fields.

Cheng B, Chatzinoff Y, Szczepanski D, Bing C, Shaikh S, Wyman O, Perry CE, Richardson JA, Burns DK, Evers BM, Greenberg DE, Chopra R.

PLoS One. 2018 May 10;13(5):e0197380. doi: 10.1371/journal.pone.0197380. eCollection 2018.

16.

Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.

Pottier C, Zhou X, Perkerson RB 3rd, Baker M, Jenkins GD, Serie DJ, Ghidoni R, Benussi L, Binetti G, López de Munain A, Zulaica M, Moreno F, Le Ber I, Pasquier F, Hannequin D, Sánchez-Valle R, Antonell A, Lladó A, Parsons TM, Finch NA, Finger EC, Lippa CF, Huey ED, Neumann M, Heutink P, Synofzik M, Wilke C, Rissman RA, Slawek J, Sitek E, Johannsen P, Nielsen JE, Ren Y, van Blitterswijk M, DeJesus-Hernandez M, Christopher E, Murray ME, Bieniek KF, Evers BM, Ferrari C, Rollinson S, Richardson A, Scarpini E, Fumagalli GG, Padovani A, Hardy J, Momeni P, Ferrari R, Frangipane F, Maletta R, Anfossi M, Gallo M, Petrucelli L, Suh E, Lopez OL, Wong TH, van Rooij JGJ, Seelaar H, Mead S, Caselli RJ, Reiman EM, Noel Sabbagh M, Kjolby M, Nykjaer A, Karydas AM, Boxer AL, Grinberg LT, Grafman J, Spina S, Oblak A, Mesulam MM, Weintraub S, Geula C, Hodges JR, Piguet O, Brooks WS, Irwin DJ, Trojanowski JQ, Lee EB, Josephs KA, Parisi JE, Ertekin-Taner N, Knopman DS, Nacmias B, Piaceri I, Bagnoli S, Sorbi S, Gearing M, Glass J, Beach TG, Black SE, Masellis M, Rogaeva E, Vonsattel JP, Honig LS, Kofler J, Bruni AC, Snowden J, Mann D, Pickering-Brown S, Diehl-Schmid J, Winkelmann J, Galimberti D, Graff C, Öijerstedt L, Troakes C, Al-Sarraj S, Cruchaga C, Cairns NJ, Rohrer JD, Halliday GM, Kwok JB, van Swieten JC, White CL 3rd, Ghetti B, Murell JR, Mackenzie IRA, Hsiung GR, Borroni B, Rossi G, Tagliavini F, Wszolek ZK, Petersen RC, Bigio EH, Grossman M, Van Deerlin VM, Seeley WW, Miller BL, Graff-Radford NR, Boeve BF, Dickson DW, Biernacka JM, Rademakers R.

Lancet Neurol. 2018 Jun;17(6):548-558. doi: 10.1016/S1474-4422(18)30126-1. Epub 2018 Apr 30.

17.

Deptor Is a Novel Target of Wnt/β-Catenin/c-Myc and Contributes to Colorectal Cancer Cell Growth.

Wang Q, Zhou Y, Rychahou P, Harris JW, Zaytseva YY, Liu J, Wang C, Weiss HL, Liu C, Lee EY, Evers BM.

Cancer Res. 2018 Jun 15;78(12):3163-3175. doi: 10.1158/0008-5472.CAN-17-3107. Epub 2018 Apr 17.

18.

Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer.

Wen YA, Xiong X, Zaytseva YY, Napier DL, Vallee E, Li AT, Wang C, Weiss HL, Evers BM, Gao T.

Cell Death Dis. 2018 Feb 15;9(3):265. doi: 10.1038/s41419-018-0330-6.

19.

Neurotensin Receptor 3/Sortilin Contributes to Tumorigenesis of Neuroendocrine Tumors Through Augmentation of Cell Adhesion and Migration.

Kim JT, Napier DL, Weiss HL, Lee EY, Townsend CM Jr, Evers BM.

Neoplasia. 2018 Feb;20(2):175-181. doi: 10.1016/j.neo.2017.11.012. Epub 2017 Dec 19.

20.

Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1.

Wang J, Ye Q, Cao Y, Guo Y, Huang X, Mi W, Liu S, Wang C, Yang HS, Zhou BP, Evers BM, She QB.

Nat Commun. 2017 Dec 20;8(1):2207. doi: 10.1038/s41467-017-02243-3.

21.

Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression.

Pi F, Binzel DW, Lee TJ, Li Z, Sun M, Rychahou P, Li H, Haque F, Wang S, Croce CM, Guo B, Evers BM, Guo P.

Nat Nanotechnol. 2018 Jan;13(1):82-89. doi: 10.1038/s41565-017-0012-z. Epub 2017 Dec 11.

22.

Stabilization of the transcription factors slug and twist by the deubiquitinase dub3 is a key requirement for tumor metastasis.

Lin Y, Wang Y, Shi Q, Yu Q, Liu C, Feng J, Deng J, Evers BM, Zhou BP, Wu Y.

Oncotarget. 2017 Aug 24;8(43):75127-75140. doi: 10.18632/oncotarget.20561. eCollection 2017 Sep 26.

23.

Lipidomic and Transcriptomic Basis of Lysosomal Dysfunction in Progranulin Deficiency.

Evers BM, Rodriguez-Navas C, Tesla RJ, Prange-Kiel J, Wasser CR, Yoo KS, McDonald J, Cenik B, Ravenscroft TA, Plattner F, Rademakers R, Yu G, White CL 3rd, Herz J.

Cell Rep. 2017 Sep 12;20(11):2565-2574. doi: 10.1016/j.celrep.2017.08.056.

24.

Diverse expression patterns and tumorigenic role of neurotensin signaling components in colorectal cancer cells.

Kim JT, Weiss HL, Evers BM.

Int J Oncol. 2017 Jun;50(6):2200-2206. doi: 10.3892/ijo.2017.3990. Epub 2017 May 9.

25.

Temperature induces significant changes in both glycolytic reserve and mitochondrial spare respiratory capacity in colorectal cancer cell lines.

Mitov MI, Harris JW, Alstott MC, Zaytseva YY, Evers BM, Butterfield DA.

Exp Cell Res. 2017 May 15;354(2):112-121. doi: 10.1016/j.yexcr.2017.03.046. Epub 2017 Mar 22.

26.

Fluorinated N,N'-Diarylureas As Novel Therapeutic Agents Against Cancer Stem Cells.

Kenlan DE, Rychahou P, Sviripa VM, Weiss HL, Liu C, Watt DS, Evers BM.

Mol Cancer Ther. 2017 May;16(5):831-837. doi: 10.1158/1535-7163.MCT-15-0634. Epub 2017 Mar 3.

27.

Dub3 inhibition suppresses breast cancer invasion and metastasis by promoting Snail1 degradation.

Wu Y, Wang Y, Lin Y, Liu Y, Wang Y, Jia J, Singh P, Chi YI, Wang C, Dong C, Li W, Tao M, Napier D, Shi Q, Deng J, Evers BM, Zhou BP.

Nat Commun. 2017 Feb 15;8:14228. doi: 10.1038/ncomms14228.

28.

Colorectal cancer: A new innate immune sensor - functions from inside the colonic epithelium.

Gao T, Evers BM.

Nat Rev Gastroenterol Hepatol. 2017 Apr;14(4):199-200. doi: 10.1038/nrgastro.2017.10. Epub 2017 Feb 15. No abstract available.

PMID:
28196986
29.

Ketogenesis contributes to intestinal cell differentiation.

Wang Q, Zhou Y, Rychahou P, Fan TW, Lane AN, Weiss HL, Evers BM.

Cell Death Differ. 2017 Mar;24(3):458-468. doi: 10.1038/cdd.2016.142. Epub 2016 Dec 9.

30.

KLF4 deletion alters gastric cell lineage and induces MUC2 expression.

Yu T, Chen X, Lin T, Liu J, Li M, Zhang W, Xu X, Zhao W, Liu M, Napier DL, Wang C, Evers BM, Liu C.

Cell Death Dis. 2016 Jun 9;7(6):e2255. doi: 10.1038/cddis.2016.158.

31.

Radiation-enhanced therapeutic targeting of galectin-1 enriched malignant stroma in triple negative breast cancer.

Upreti M, Jyoti A, Johnson SE, Swindell EP, Napier D, Sethi P, Chan R, Feddock JM, Weiss HL, O'Halloran TV, Evers BM.

Oncotarget. 2016 Jul 5;7(27):41559-41574. doi: 10.18632/oncotarget.9490.

32.

An obligatory role for neurotensin in high-fat-diet-induced obesity.

Li J, Song J, Zaytseva YY, Liu Y, Rychahou P, Jiang K, Starr ME, Kim JT, Harris JW, Yiannikouris FB, Katz WS, Nilsson PM, Orho-Melander M, Chen J, Zhu H, Fahrenholz T, Higashi RM, Gao T, Morris AJ, Cassis LA, Fan TW, Weiss HL, Dobner PR, Melander O, Jia J, Evers BM.

Nature. 2016 May 19;533(7603):411-5. doi: 10.1038/nature17662. Epub 2016 May 11.

33.

Cancer stem cell marker expression alone and in combination with microvascular invasion predicts poor prognosis in patients undergoing transplantation for hepatocellular carcinoma.

Vilchez V, Turcios L, Zaytseva Y, Stewart R, Lee EY, Maynard E, Shah MB, Daily MF, Tzeng CW, Davenport D, Castellanos AL, Krohmer S, Hosein PJ, Evers BM, Gedaly R.

Am J Surg. 2016 Aug;212(2):238-45. doi: 10.1016/j.amjsurg.2015.12.019. Epub 2016 Feb 27.

PMID:
27033253
34.

PI(4)P Promotes Phosphorylation and Conformational Change of Smoothened through Interaction with Its C-terminal Tail.

Jiang K, Liu Y, Fan J, Zhang J, Li XA, Evers BM, Zhu H, Jia J.

PLoS Biol. 2016 Feb 10;14(2):e1002375. doi: 10.1371/journal.pbio.1002375. eCollection 2016 Feb.

35.

Controllable self-assembly of RNA dendrimers.

Sharma A, Haque F, Pi F, Shlyakhtenko LS, Evers BM, Guo P.

Nanomedicine. 2016 Apr;12(3):835-844. doi: 10.1016/j.nano.2015.11.008. Epub 2015 Dec 2.

36.

Activation of AMPK Stimulates Neurotensin Secretion in Neuroendocrine Cells.

Li J, Song J, Weiss HL, Weiss T, Townsend CM Jr, Evers BM.

Mol Endocrinol. 2016 Jan;30(1):26-36. doi: 10.1210/me.2015-1094. Epub 2015 Nov 3.

37.

Differential expression and tumorigenic function of neurotensin receptor 1 in neuroendocrine tumor cells.

Kim JT, Li J, Song J, Lee EY, Weiss HL, Townsend CM Jr, Evers BM.

Oncotarget. 2015 Sep 29;6(29):26960-70. doi: 10.18632/oncotarget.4745.

38.

The role of ROS generation from magnetic nanoparticles in an alternating magnetic field on cytotoxicity.

Wydra RJ, Rychahou PG, Evers BM, Anderson KW, Dziubla TD, Hilt JZ.

Acta Biomater. 2015 Oct;25:284-90. doi: 10.1016/j.actbio.2015.06.037. Epub 2015 Jul 2. Erratum in: Acta Biomater. 2016 Mar;33:322-3.

39.

RNA Nanoparticles Derived from Three-Way Junction of Phi29 Motor pRNA Are Resistant to I-125 and Cs-131 Radiation.

Li H, Rychahou PG, Cui Z, Pi F, Evers BM, Shu D, Guo P, Luo W.

Nucleic Acid Ther. 2015 Aug;25(4):188-97. Epub 2015 May 27.

40.

Increased expression of fatty acid synthase provides a survival advantage to colorectal cancer cells via upregulation of cellular respiration.

Zaytseva YY, Harris JW, Mitov MI, Kim JT, Butterfield DA, Lee EY, Weiss HL, Gao T, Evers BM.

Oncotarget. 2015 Aug 7;6(22):18891-904.

41.

Methods and assays for specific targeting and delivery of RNA nanoparticles to cancer metastases.

Rychahou P, Shu Y, Haque F, Hu J, Guo P, Evers BM.

Methods Mol Biol. 2015;1297:121-35. doi: 10.1007/978-1-4939-2562-9_9.

PMID:
25896000
42.

Chaperone Hsp47 Drives Malignant Growth and Invasion by Modulating an ECM Gene Network.

Zhu J, Xiong G, Fu H, Evers BM, Zhou BP, Xu R.

Cancer Res. 2015 Apr 15;75(8):1580-91. doi: 10.1158/0008-5472.CAN-14-1027. Epub 2015 Mar 5.

43.

The evolving role of the surgeon scientist.

Evers BM.

J Am Coll Surg. 2015 Apr;220(4):387-95. doi: 10.1016/j.jamcollsurg.2014.12.044. Epub 2015 Jan 14. No abstract available.

PMID:
25724605
44.

TSC2/mTORC1 signaling controls Paneth and goblet cell differentiation in the intestinal epithelium.

Zhou Y, Rychahou P, Wang Q, Weiss HL, Evers BM.

Cell Death Dis. 2015 Feb 5;6:e1631. doi: 10.1038/cddis.2014.588.

45.

Delivery of RNA nanoparticles into colorectal cancer metastases following systemic administration.

Rychahou P, Haque F, Shu Y, Zaytseva Y, Weiss HL, Lee EY, Mustain W, Valentino J, Guo P, Evers BM.

ACS Nano. 2015 Feb 24;9(2):1108-16. doi: 10.1021/acsnano.5b00067. Epub 2015 Feb 10.

46.

A new cecal slurry preparation protocol with improved long-term reproducibility for animal models of sepsis.

Starr ME, Steele AM, Saito M, Hacker BJ, Evers BM, Saito H.

PLoS One. 2014 Dec 22;9(12):e115705. doi: 10.1371/journal.pone.0115705. eCollection 2014.

47.

Increased coagulation and suppressed generation of activated protein C in aged mice during intra-abdominal sepsis.

Starr ME, Takahashi H, Okamura D, Zwischenberger BA, Mrazek AA, Ueda J, Stromberg AJ, Evers BM, Esmon CT, Saito H.

Am J Physiol Heart Circ Physiol. 2015 Jan 15;308(2):H83-91. doi: 10.1152/ajpheart.00289.2014. Epub 2014 Nov 7.

48.

Age-Associated Increase in Cytokine Production During Systemic Inflammation-II: The Role of IL-1β in Age-Dependent IL-6 Upregulation in Adipose Tissue.

Starr ME, Saito M, Evers BM, Saito H.

J Gerontol A Biol Sci Med Sci. 2015 Dec;70(12):1508-15. doi: 10.1093/gerona/glu197. Epub 2014 Oct 24.

49.

Neurotensin, a novel target of Wnt/β-catenin pathway, promotes growth of neuroendocrine tumor cells.

Kim JT, Liu C, Zaytseva YY, Weiss HL, Townsend CM Jr, Evers BM.

Int J Cancer. 2015 Mar 15;136(6):1475-81. doi: 10.1002/ijc.29123. Epub 2014 Aug 14.

50.

Nuclear factor of activated T-cells 5 increases intestinal goblet cell differentiation through an mTOR/Notch signaling pathway.

Zhou Y, Wang Q, Weiss HL, Evers BM.

Mol Biol Cell. 2014 Sep 15;25(18):2882-90. doi: 10.1091/mbc.E14-05-0998. Epub 2014 Jul 23.

Supplemental Content

Loading ...
Support Center